205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.08%
Revenue growth above 1.5x ADI's 3.20%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
4.16%
Gross profit growth at 75-90% of ADI's 4.94%. Bill Ackman would demand operational improvements to match competitor gains.
2800.34%
EBIT growth above 1.5x ADI's 9.02%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
2800.34%
Operating income growth above 1.5x ADI's 9.02%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
1.08%
Net income growth under 50% of ADI's 10.15%. Michael Burry would suspect the firm is falling well behind a key competitor.
-15.38%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-15.38%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.25%
Share reduction more than 1.5x ADI's 241.28%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.83%
Reduced diluted shares while ADI is at 241.28%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
4.28%
Dividend growth of 4.28% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
8.56%
OCF growth under 50% of ADI's 93.22%. Michael Burry might suspect questionable revenue recognition or rising costs.
11.00%
FCF growth similar to ADI's 12.02%. Walter Schloss would attribute it to parallel capital spending and operational models.
87.72%
10Y revenue/share CAGR above 1.5x ADI's 40.69%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
34.54%
5Y revenue/share CAGR above 1.5x ADI's 10.85%. David Dodd would look for consistent product or market expansions fueling outperformance.
46.44%
Positive 3Y CAGR while ADI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
30.37%
Below 50% of ADI's 85.84%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
13.89%
3Y OCF/share CAGR under 50% of ADI's 354.72%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
473.10%
10Y net income/share CAGR of 473.10% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
370.76%
Below 50% of ADI's 2524.32%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
303.98%
3Y net income/share CAGR 50-75% of ADI's 571.56%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
73.62%
10Y equity/share CAGR above 1.5x ADI's 19.53%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
9.94%
Positive 5Y equity/share CAGR while ADI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
43.36%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
-25.54%
Cut dividends over 10 years while ADI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-13.13%
Negative 5Y dividend/share CAGR while ADI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-11.62%
Negative near-term dividend growth while ADI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-1.10%
Firm’s AR is declining while ADI shows 5.18%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.38%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.13%
Asset growth well under 50% of ADI's 8.48%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
5.88%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
-4.09%
We’re deleveraging while ADI stands at 0.58%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
6.96%
SG&A growth well above ADI's 1.15%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.